QUOTE AND NEWS
TheStreet.com  Nov 3  Comment 
Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.  TheStreet Ratings quantitative algorithm...
StreetInsider.com  Oct 28  Comment 
InvenSense (NYSE: INVN) 25.3% LOWER ; reported Q2 EPS of $0.05, $0.11 worse than the analyst estimate of $0.16. Revenue for the quarter came in at $90.2 million versus the consensus estimate of $90.48 million. XOOM (NASDAQ: XOOM) 12.6% LOWER ;...
Motley Fool  Oct 28  Comment 
Zeltiq's CoolScuplting heats up again this quarter.
Motley Fool  Oct 27  Comment 
Zeltiq's CoolScuplting is heating up.
StreetInsider.com  Sep 2  Comment 
The following is a list of notable articles to help get you through the lunch hour: BlackBerry (BBRY) Plans Sept. 24th Events in Three non-U.S. Cities -> Read this! ZELTIQ Aesthetics (ZLTQ) Gains on Bullish Stifel Research -> Read this! Weak...
DailyFinance  Aug 22  Comment 
PLEASANTON, CA -- (Marketwired) -- 08/22/14 -- ZELTIQ® (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced that Mark...
SeekingAlpha  Jul 31  Comment 
Hickey and Walters (Bespoke) submit: This morning's batch of earnings reports put us over the 1,000-report mark for the current earnings season. So far this season, the average stock that has reported has gained 0.02% on the day of its report,...
Benzinga  Jul 30  Comment 
Midway through trading Wednesday, the Dow traded down 0.50 percent to 16,827.09 while the NASDAQ surged 0.14 percent to 4,448.84. The S&P also fell, dropping 0.28 percent to 1,964.42. Leading and Lagging Sectors Wednesday morning, the...




 
TOP CONTRIBUTORS

ZELTIQ Aesthetics (NASDAQ:ZLTQ) is a medical device company which developed and sells a fat reduction device called CoolSculpting. The system selectively cools regions of fat to increase their rate of elimination by the body. The procedure is targeted for individuals with relatively small fat bulges rather than for obese individuals. This is because the technology is typically ineffective on obese individuals who require significant decreases in their body fat. Zeltiq makes money by selling the systems to physicians as well as charging procedure fees for each treatment performed.[1]

Business Overview

Zeltiq's total revenue for the full year 2010 was $25.5M. This compares to a total revenue of $1.6M in 2009. However, the company reported a net loss of 2010 of $13.5M. This is an improvement over the net loss of $17.6M in 2009. While Zeltiq has historically had a large research and development expense, this costs was surpassed by sales and marketing in 2010. [2]

New Updates

The company's initial public offering of stock on the NASDAQ occurred on October 18, 2011. The company offered 7M shares each for $13. This was below the $14-$16 price range. The company raised $91M through the deal. The lead managers of the deal were JP Morgan and Goldman.[3]

Trends & Forces

Reliance on luxury health

Because Zeltiq's devices aim to help individuals with relatively small fat bulges, the demand for their product is largely an additional luxury good. Unlike procedures aimed at obese individuals, the use of CoolSculpting does not prevent or solve an immediate health risk. As a result, demand for such a service will rest on individuals who are willing and able to pay for cosmetic improvements. By contrast, since the procedure is noninvasive and treats fat bulges, the potential demand for the product is likely quite large. [4][5]

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki